Jona, the AI-powered gut microbiome company, today announced a partnership with Everlywell, the leading at-home lab testing company in the U.S., to bring professional-grade microbiome analysis to consumers nationwide. For the first time on Everlywell’s established diagnostics platform, customers can access advanced gut microbiome testing powered by deep shotgun metagenomic sequencing and Jona’s proprietary AI. This next-generation test delivers personalized insights into one of the most consequential and fast-moving frontiers in health: the gut microbiome’s influence on digestion, immunity, metabolism, and beyond.
“Our mission has always been to make the microbiome actionable, not just measurable,” said Leo Grady, PhD, Founder and CEO at Jona. “Partnering with Everlywell extends that reach to 60 million+ people already invested in their health.”
Through Everlywell’s platform, customers can access the most advanced, AI-powered microbiome test on the market, sequencing every organism to the strain level and connecting findings to over 220,000 peer-reviewed studies. Jona’s digital twin technology then models how targeted dietary, probiotic, and lifestyle interventions are likely to shift the microbiome, translating this scientific rigor into a personalized action plan with diet and lifestyle guidance.
“This launch adds a crucial new offering to our trusted digestive health portfolio: deep, data-driven microbiome intelligence,” said Matt O’Connor, General Manager of Everlywell’s Consumer division. “For people who have felt stuck or overlooked, this advanced gut microbiome test goes beyond surface-level results, providing deeper, more personalized insights to help you understand the root cause of your symptoms.”
“The microbiome is a new frontier of health. Deeply understanding it will transform diagnostics, nutrition, and treatment pathways across medicine. At the same time, making high-resolution, evidence-based microbiome analysis available at scale democratizes cutting-edge scientific insights and enables a new phase of precision, scale, and real-world relevance,” said Jonas Schluter, PhD, Chief Scientific Advisor at Jona.
The Jona Gut Microbiome Test is now available at Everlywell.
Microbiome research has linked gut health to GI, cardiovascular, neurological, metabolic, autoimmune, dermatologic, and performance-related conditions, yet for many clinicians and consumers, turning complex microbiome data into clear clinical action remains a challenge. Using deep shotgun metagenomic sequencing and a proprietary AI engine trained on more than 220,000 peer-reviewed studies, Jona identifies disease-associated microbial signatures at the strain level. Its digital twin technology then models how targeted dietary, probiotic, and lifestyle interventions are likely to shift the microbiome, delivering a Personalized Action Plan. Learn more at jona.health.
About Everlywell
Everlywell is a digital health company pioneering the next generation of biomarker intelligence — combining AI-powered technology with human insight to deliver personalized, actionable health answers. In 2025, an estimated 1 in 94 U.S. adults received an Everlywell test, solidifying our spot as the #1 at-home lab testing company in the country. Fueled by AI and built for scale, we’re breaking down barriers, closing care gaps, and unlocking a more connected healthcare experience that is smarter, faster, and more personalized. Learn more at everlywell.com.
media@jona.health
Jona, Inc.
media@everlywell.com
Everlywell
